Not specifically. Whilst both equally target GLP-one receptors, Tirz also activates GIP receptors, which makes it a twin agonist. This broader system is believed to boost its outcomes on insulin sensitivity and appetite signaling in investigation versions. Las investigaciones sobre este péptido también abren la puerta a un mayor conocimiento https://peptisell.com/product/tirzepatide